Skip to main content
Clinical Trials/NL-OMON49104
NL-OMON49104
Completed
Not Applicable

sing Continuous Glucose Monitoring and contextual data to increase insight in glucose patterns for individuals with type 2 diabetes. - Gluco-Insight

TNO0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
TNO
Enrollment
40
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
TNO

Eligibility Criteria

Inclusion Criteria

  • \* Aged \< 80 years
  • \* BMI 25 \* 40 kg/m2, with preference for \< 35 kg/m2; BMI 20\-25 kg/m2 is also
  • allowed if aged 60\-80 years
  • \* Diagnosed with type 2 diabetes mellitus
  • \* Insulin naïve
  • \* Using either lifestyle and/or metformin for managing their diabetes
  • \* Able to answer questionnaires in Dutch
  • \* In possession of a Smartphone running on a recent version of iOS or Android
  • \* Able and willing to sign the informed consent form
  • \* Willing to comply with all study procedures

Exclusion Criteria

  • \* Insufficient motivation to be in the study
  • \* Unavailability for more than 2 weeks in a row during the study period
  • \* A condition that would need an MRI in the upcoming 6 months
  • \* History of bariatric weight loss surgery
  • \* Planned (bariatric) surgery in the upcoming 6 months
  • \* Active cancer or chemotherapy or radiation within 2 years prior to
  • participation
  • \* Chronic medical condition, treatment, or medication other than diabetes that
  • may affect glucose metabolism (HIV diagnosis, use of steroids or
  • immunosuppressive drugs, etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials